ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

Satcher Nominated For Surgeon General, Asst. Sec. for Health.

September 19, 1997

FDA Approved 88% Of Cancer Applications Since Oncology Office Opened In 2005.

July 3, 2008

St. Jude Children’s Research Hospital Wins NCI Designation As Comprehensive.

May 16, 2008

In Brief: Moloney, Manaher, 11 Other NCI Staff Members Retire; Terry Takes Leave From Immunology Jobs

March 7, 1980

PhRMA Tightens DTC Restrictions, But Dingell Says It’s Not Enough.

December 12, 2008

Garb’s Questions, Answers About Cancer Program

December 5, 1980